Mesoblast ^Investors

Mesoblast is a leading medicine company specializing in regenerative medicine. They develop biologic products using their patented Mesenchymal Precursor Cell (MPC) technology. Their products are aimed at treating a wide range of clinical diseases, including inflammatory and immunologic conditions, diabetes, kidney disease, orthopedic spine conditions, and cardiovascular disorders. Mesoblast's innovative approach to regenerative medicine has garnered significant attention and they continue to make strides in the field with their groundbreaking products.